Valuation: 10x Genomics, Inc.

Market Cap 6.1B 5.37B 4.99B 4.59B 8.6B 591B 8.75B 59.61B 23.25B 288B 22.91B 22.41B 1T P/E 2026 *
-59.2x
P/E 2027 * -68.8x
Enterprise Value 5.62B 4.95B 4.59B 4.23B 7.92B 545B 8.07B 54.94B 21.43B 266B 21.11B 20.65B 921B EV / Sales 2026 *
9.16x
EV / Sales 2027 * 8.27x
Free-Float
90.53%
Yield 2026 *
-
Yield 2027 * -
1 day+0.80%
1 week+8.05%
Current month+25.35%
1 month+50.80%
3 months+124.37%
6 months+114.75%
Current year+194.67%
1 week 41.93
Extreme 41.93
49.5
1 month 34.5
Extreme 34.495
49.5
Current year 15.9
Extreme 15.9
49.5
1 year 11.16
Extreme 11.16
49.5
3 years 6.78
Extreme 6.78
63.57
5 years 6.78
Extreme 6.78
191.15
10 years 6.78
Extreme 6.78
208.99
Manager TitleAgeSince
Chief Executive Officer 49 2012-07-01
President 51 2012-09-30
Director of Finance/CFO 51 2024-08-11
Director TitleAgeSince
Director/Board Member 51 2012-07-01
Director/Board Member 49 2012-07-01
Chairman 68 2013-07-31
Date Insider Type Main position Quantity % Market Cap.
6/22/26 Sell

Founder

-30,000 0.0257%
6/16/26 Sell

Director

-5,723 0.0049%
6/4/26 Free

Director

8,829 0.0076%
Change 5-day change 1-year change 3-year change Capi.($)
+2.15%+8.05%+252.86%-19.85% 6.1B
-0.36%-3.10%+230.47%+298.83% 19.92B
-0.43%-5.89%-45.30%-27.99% 9.25B
-0.84%-1.31%+41.50%+18.49% 6.75B
-1.59%+5.91%-12.16%-23.02% 5.53B
-10.00%+2.06%+88.80%+110.73% 4.55B
+1.76%-5.04%-47.89% - 4.42B
+0.12%-3.49%-26.42%-28.84% 4.03B
-1.68%-2.81%-16.61%-39.76% 2.71B
+0.92%-13.04%-32.46%+204.93% 1.62B
Average -1.13%-1.48%+43.28%+54.84% 6.49B
Weighted average by Cap. -0.94%-1.76%+91.16%+102.21%

Financials

2026 *2027 *
Net sales 614M 540M 502M 461M 865M 59.47B 881M 6B 2.34B 29.01B 2.31B 2.26B 101B 671M 591M 549M 505M 946M 65.03B 963M 6.56B 2.56B 31.72B 2.52B 2.47B 110B
Net income -104M -91.88M -85.35M -78.5M -147M -10.12B -150M -1.02B -398M -4.93B -392M -384M -17.12B -90.68M -79.76M -74.09M -68.14M -128M -8.78B -130M -886M -346M -4.28B -340M -333M -14.86B
Net Debt -478M -421M -391M -359M -674M -46.32B -686M -4.67B -1.82B -22.59B -1.8B -1.76B -78.38B -548M -482M -448M -412M -772M -53.07B -786M -5.35B -2.09B -25.89B -2.06B -2.01B -89.81B
Logo 10x Genomics, Inc.
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
Employees
1,178
Date Price Change Volume
26-07-23 US$48.06 +2.15% 2,985,305
26-07-22 US$47.05 -0.32% 2,822,554
26-07-21 US$47.20 +9.21% 2,465,300
26-07-20 US$43.22 -1.19% 2,383,841
26-07-17 US$43.74 -1.66% 2,567,096
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
48.06USD
Average target price
41.54USD
Spread / Average Target
-13.57%

Quarterly revenue - Rate of surprise